Article
Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
Human mutation - 1 Feb 2002
Emre Serap, Terzioglu Mugen, Tokatli Aysegul, Coskun Turgay, Ozalp Imran, Weber Birgit, Hopwood John J
Abstract excerpt
Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease. MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and a-N-acetylglucosaminidase (NAGLU) deficient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
